-
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies
27 Jan 2025 23:07 GMT
… of the collaboration.
Breast cancer and HER2 expression
Breast cancer is the second … and in new breast cancer settings.
In HR-positive breast cancer, AstraZeneca continues … with triple-negative breast cancer, an aggressive form of breast cancer, AstraZeneca is …
-
ENHERTU® Approved in the U.S. as First HER2 Directed Therapy for Patients with HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following Disease Progression After One or More Endocrine Therapies
27 Jan 2025 23:07 GMT
… of HR positive metastatic breast cancer and following progression, … gov.
About Breast Cancer and HER2 Expression
Breast cancer is the second … Breast Cancer. Accessed January 2025.
3 National Cancer Institute. SEER Cancer Stat Facts: Female Breast Cancer …
-
FDA Approves Trastuzumab Deruxtecan for Pretreated HER2-Low and -Ultralow Metastatic Breast Cancer
28 Jan 2025 00:37 GMT
… of hormone receptor–positive metastatic breast cancer, and following progression, subsequent … low or HER2-ultralow metastatic breast cancer following endocrine therapy.”
The … with hormone receptor–positive metastatic breast cancer with low HER2 expression ( …
-
FDA Approves T-DXd in HR+, HER2-Low/Ultralow Breast Cancer
28 Jan 2025 00:55 GMT
… without targeted therapy for metastatic breast cancer. Alternatively, they could have 1 … -low or HER2-ultralow metastatic breast cancer following disease progression after one … )-low or HER2-ultralow metastatic breast cancer (mBC) with prior endocrine therapy …
-
FDA Approves T-DXd for Previously Treated HER2-Low and -Ultralow Metastatic Breast Cancer
28 Jan 2025 00:25 GMT
… HER2-low -ultralow metastatic breast cancer.
“Endocrine therapy is typically … of hormone receptor–positive metastatic breast cancer, and following progression, subsequent … low or HER2-ultralow metastatic breast cancer following endocrine therapy.”
Reference …
-
FDA Approves T-DXd in HER2-Low/Ultralow Breast Cancer
28 Jan 2025 01:51 GMT
… HER2-ultralow advanced or metastatic breast cancer.2
Results that were previously … -low or HER2-ultralow metastatic breast cancer following disease progression after one … -Breast06. Presented at: San Antonio Breast Cancer Conference; December 10-13, 2024 …
-
Concerns as breast cancer diagnoses trend upwards among young women
27 Jan 2025 20:47 GMT
… are being diagnosed with breast cancer despite the common misconception … was first diagnosed with breast cancer two days after her … really know much about breast cancer, I thought it was … . Credit: 7NEWSIn 2023, breast cancer was the most commonly diagnosed …
-
46-year-old breast cancer patient undergoes minimally invasive mastectomy and reconstruction
27 Jan 2025 19:52 GMT
… ), a procedure that involves cancer removal and breast reconstruction through a minimally … was diagnosed with early-stage breast cancer and was advised to undergo … improving awareness about advancements in breast cancer and the need for early …
-
'I was ghosted when I got breast cancer - friends would cross the road rather than talk to me'
27 Jan 2025 19:21 GMT
… distant. David McCallion, who had breast cancer, experienced this firsthand when an … , was first diagnosed with breast cancer at the age of 54 … , ‘you can’t have breast cancer. That’s a woman’s … men don't get breast cancer and felt invalidated
(
Image:
…
-
Olivia Clarke, who started group aimed at helping cancer patients with humor, dies
28 Jan 2025 02:10 GMT
… after being diagnosed with breast cancer, started a nonprofit called … died of complications from breast cancer Jan. 15 at … breast cancer. After treatment, she was declared cancer-free, but her cancer … Chicago-based nonprofit cancer support association Gilda’ …